Hypermarcas (OTCMKTS:HYPMY) Posts Quarterly Earnings Results

Hypermarcas (OTCMKTS:HYPMY) issued its earnings results on Thursday. The company reported $0.13 EPS for the quarter, Zacks reports. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The business had revenue of $414.22 million during the quarter.

Hypermarcas Stock Down 1.2%

Hypermarcas stock traded down $0.05 during mid-day trading on Friday, reaching $4.05. The stock had a trading volume of 6,284 shares, compared to its average volume of 15,007. The firm has a market capitalization of $2.56 billion, a PE ratio of 17.59 and a beta of 0.73. Hypermarcas has a fifty-two week low of $3.17 and a fifty-two week high of $5.50. The stock’s 50-day simple moving average is $4.48 and its 200-day simple moving average is $4.42. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.